Cargando…

CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

SIMPLE SUMMARY: The management of intraductal papillary mucinous neoplasms of the pancreas (IPMN) remains controversial due to the relatively high rate of unnecessary surgery for low grade dysplasia (LGD) despite the last international recommendations. The aim of our retrospective study was to asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobaly, David, Santinha, Joao, Sartoris, Riccardo, Dioguardi Burgio, Marco, Matos, Celso, Cros, Jérôme, Couvelard, Anne, Rebours, Vinciane, Sauvanet, Alain, Ronot, Maxime, Papanikolaou, Nikolaos, Vilgrain, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690711/
https://www.ncbi.nlm.nih.gov/pubmed/33114028
http://dx.doi.org/10.3390/cancers12113089
_version_ 1783614130772508672
author Tobaly, David
Santinha, Joao
Sartoris, Riccardo
Dioguardi Burgio, Marco
Matos, Celso
Cros, Jérôme
Couvelard, Anne
Rebours, Vinciane
Sauvanet, Alain
Ronot, Maxime
Papanikolaou, Nikolaos
Vilgrain, Valérie
author_facet Tobaly, David
Santinha, Joao
Sartoris, Riccardo
Dioguardi Burgio, Marco
Matos, Celso
Cros, Jérôme
Couvelard, Anne
Rebours, Vinciane
Sauvanet, Alain
Ronot, Maxime
Papanikolaou, Nikolaos
Vilgrain, Valérie
author_sort Tobaly, David
collection PubMed
description SIMPLE SUMMARY: The management of intraductal papillary mucinous neoplasms of the pancreas (IPMN) remains controversial due to the relatively high rate of unnecessary surgery for low grade dysplasia (LGD) despite the last international recommendations. The aim of our retrospective study was to assess the performance of radiomic analysis on CT in differentiating benign from malignant IPMN. We confirmed in a training cohort (296 patients) and a validation cohort (112 patients) that a total of 85 radiomics features provided valuable additional and independent information for discriminating benign from malignant tumors in the training cohort with an area under the ROC curve (AUC) of 0.84 and an external validation with an AUC of 0.71 with higher performance when implementing clinical variables leading to the indication to surgery. We have demonstrated the capabilities of radiomics models comprising LGD versus high-grade dysplasia (HGD) versus invasive, LGD and HGD, HGD and invasive. ABSTRACT: To assess the performance of CT-based radiomics analysis in differentiating benign from malignant intraductal papillary mucinous neoplasms of the pancreas (IPMN), preoperative scans of 408 resected patients with IPMN were retrospectively analyzed. IPMNs were classified as benign (low-grade dysplasia, n = 181), or malignant (high grade, n = 128, and invasive, n = 99). Clinicobiological data were reported. Patients were divided into a training cohort (TC) of 296 patients and an external validation cohort (EVC) of 112 patients. After semi-automatic tumor segmentation, PyRadiomics was used to extract radiomics features. A multivariate model was developed using a logistic regression approach. In the training cohort, 85/107 radiomics features were significantly different between patients with benign and malignant IPMNs. Unsupervised clustering analysis revealed four distinct clusters of patients with similar radiomics features patterns with malignancy as the most significant association. The multivariate model differentiated benign from malignant tumors in TC with an area under the ROC curve (AUC) of 0.84, sensitivity (Se) of 0.82, specificity (Spe) of 0.74, and in EVC with an AUC of 0.71, Se of 0.69, Spe of 0.57. This large study confirms the high diagnostic performance of preoperative CT-based radiomics analysis to differentiate between benign from malignant IPMNs.
format Online
Article
Text
id pubmed-7690711
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76907112020-11-27 CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas Tobaly, David Santinha, Joao Sartoris, Riccardo Dioguardi Burgio, Marco Matos, Celso Cros, Jérôme Couvelard, Anne Rebours, Vinciane Sauvanet, Alain Ronot, Maxime Papanikolaou, Nikolaos Vilgrain, Valérie Cancers (Basel) Article SIMPLE SUMMARY: The management of intraductal papillary mucinous neoplasms of the pancreas (IPMN) remains controversial due to the relatively high rate of unnecessary surgery for low grade dysplasia (LGD) despite the last international recommendations. The aim of our retrospective study was to assess the performance of radiomic analysis on CT in differentiating benign from malignant IPMN. We confirmed in a training cohort (296 patients) and a validation cohort (112 patients) that a total of 85 radiomics features provided valuable additional and independent information for discriminating benign from malignant tumors in the training cohort with an area under the ROC curve (AUC) of 0.84 and an external validation with an AUC of 0.71 with higher performance when implementing clinical variables leading to the indication to surgery. We have demonstrated the capabilities of radiomics models comprising LGD versus high-grade dysplasia (HGD) versus invasive, LGD and HGD, HGD and invasive. ABSTRACT: To assess the performance of CT-based radiomics analysis in differentiating benign from malignant intraductal papillary mucinous neoplasms of the pancreas (IPMN), preoperative scans of 408 resected patients with IPMN were retrospectively analyzed. IPMNs were classified as benign (low-grade dysplasia, n = 181), or malignant (high grade, n = 128, and invasive, n = 99). Clinicobiological data were reported. Patients were divided into a training cohort (TC) of 296 patients and an external validation cohort (EVC) of 112 patients. After semi-automatic tumor segmentation, PyRadiomics was used to extract radiomics features. A multivariate model was developed using a logistic regression approach. In the training cohort, 85/107 radiomics features were significantly different between patients with benign and malignant IPMNs. Unsupervised clustering analysis revealed four distinct clusters of patients with similar radiomics features patterns with malignancy as the most significant association. The multivariate model differentiated benign from malignant tumors in TC with an area under the ROC curve (AUC) of 0.84, sensitivity (Se) of 0.82, specificity (Spe) of 0.74, and in EVC with an AUC of 0.71, Se of 0.69, Spe of 0.57. This large study confirms the high diagnostic performance of preoperative CT-based radiomics analysis to differentiate between benign from malignant IPMNs. MDPI 2020-10-23 /pmc/articles/PMC7690711/ /pubmed/33114028 http://dx.doi.org/10.3390/cancers12113089 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tobaly, David
Santinha, Joao
Sartoris, Riccardo
Dioguardi Burgio, Marco
Matos, Celso
Cros, Jérôme
Couvelard, Anne
Rebours, Vinciane
Sauvanet, Alain
Ronot, Maxime
Papanikolaou, Nikolaos
Vilgrain, Valérie
CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
title CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
title_full CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
title_fullStr CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
title_full_unstemmed CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
title_short CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
title_sort ct-based radiomics analysis to predict malignancy in patients with intraductal papillary mucinous neoplasm (ipmn) of the pancreas
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690711/
https://www.ncbi.nlm.nih.gov/pubmed/33114028
http://dx.doi.org/10.3390/cancers12113089
work_keys_str_mv AT tobalydavid ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas
AT santinhajoao ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas
AT sartorisriccardo ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas
AT dioguardiburgiomarco ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas
AT matoscelso ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas
AT crosjerome ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas
AT couvelardanne ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas
AT reboursvinciane ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas
AT sauvanetalain ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas
AT ronotmaxime ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas
AT papanikolaounikolaos ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas
AT vilgrainvalerie ctbasedradiomicsanalysistopredictmalignancyinpatientswithintraductalpapillarymucinousneoplasmipmnofthepancreas